CREO fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Creo Medical Group Plc operates as a medical device company that focuses on surgical endoscopy. It develops CROMA, an electrosurgical platform that delivers microwave and bipolar radio frequency for precise localized cutting and microwave for controlled coagulation. The company was founded by Mohammed Sabih Chaudhry on September 12, 2016 and is headquartered in Chepstow, the United Kingdom.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
CREO has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company